Cargando…

BMNet: A New Region-Based Metric Learning Method for Early Alzheimer’s Disease Identification With FDG-PET Images

18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) reveals altered brain metabolism in individuals with mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Some biomarkers derived from FDG-PET by computer-aided-diagnosis (CAD) technologies have been proved that they can accura...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Wenju, Yan, Caiying, Yan, Zhuangzhi, Peng, Yunsong, Leng, Yilin, Liu, Chenlu, Chen, Shuangqing, Jiang, Xi, Zheng, Jian, Yang, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908419/ https://www.ncbi.nlm.nih.gov/pubmed/35281501 http://dx.doi.org/10.3389/fnins.2022.831533

Ejemplares similares

Classification of microcalcification clusters in digital breast tomosynthesis using ensemble convolutional neural network
por: Xiao, Bingbing, et al.
Publicado: (2021)

Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images
por: Shen, Ting, et al.
Publicado: (2019)

Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease
por: Yan, Lirong, et al.
Publicado: (2017)

Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients
por: Weisman, Amy J., et al.
Publicado: (2020)

Prognostic Evaluation Based on Dual-Time (18)F-FDG PET/CT Radiomics Features in Patients with Locally Advanced Pancreatic Cancer Treated by Stereotactic Body Radiation Therapy
por: Wang, Fei, et al.
Publicado: (2022)

FDG-PET assessment of the locus coeruleus in Alzheimer’s disease
por: Liu, Kathy Y., et al.
Publicado: (2021)

FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Selection of the optimal intensity normalization region for FDG-PET studies of normal aging and Alzheimer’s disease
por: Nugent, Scott, et al.
Publicado: (2020)

(18)F-FDG-PET in Mouse Models of Alzheimer's Disease
por: Bouter, Caroline, et al.
Publicado: (2019)

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2008)

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
por: Ou, Ya-Nan, et al.
Publicado: (2019)

Classification of Alzheimer’s Disease by Combination of Convolutional and Recurrent Neural Networks Using FDG-PET Images
por: Liu, Manhua, et al.
Publicado: (2018)

Regional brain metabolism in schizophrenia: An FDG-PET study
por: Seethalakshmi, R., et al.
Publicado: (2006)

Impact of brain segmentation methods on regional metabolism quantification in (18)F-FDG PET/MR analysis
por: Shan, Yi, et al.
Publicado: (2023)

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology
por: Laforce, Robert, et al.
Publicado: (2014)

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
por: Levin, Fedor, et al.
Publicado: (2021)

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Neural Correlates of Stroop Performance in Alzheimer's Disease: A FDG-PET Study
por: Yun, Je-Yeon, et al.
Publicado: (2011)

Generative FDG-PET and MRI Model of Aging and Disease Progression in Alzheimer's Disease
por: Dukart, Juergen, et al.
Publicado: (2013)

Broad learning for early diagnosis of Alzheimer's disease using FDG-PET of the brain
por: Duan, Junwei, et al.
Publicado: (2023)

The effect of Q.Clear reconstruction on quantification and spatial resolution of 18F-FDG PET in simultaneous PET/MR
por: Tian, Defeng, et al.
Publicado: (2022)

Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma
por: Minamimoto, Ryogo, et al.
Publicado: (2016)

Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study
por: Domachevsky, Liran, et al.
Publicado: (2017)

Using 18F-FDG-PET/CT Metrics to Predict Survival in Ra-Dio-Iodine Refractory Thyroid Cancers
por: Roy, Malanie, et al.
Publicado: (2022)

Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2019)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer’s Type
por: Madhavan, Ajay, et al.
Publicado: (2013)

FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease
por: Murray, John, et al.
Publicado: (2014)

FDG PET Findings according to Wandering Patterns of Patients with Drug-naïve Alzheimer's Disease
por: Yang, YoungSoon, et al.
Publicado: (2018)

(18)F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications
por: Ye, Shuang, et al.
Publicado: (2019)

Quantitative and visual analyses of the effect of activity reduction on image metrics and quality in 18F-FDG PET/MRI in pediatric oncology
por: AYDOS, Uğuray, et al.
Publicado: (2022)

Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET
por: Promteangtrong, Chetsadaporn, et al.
Publicado: (2015)

Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2020)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

FDG-PET and colon cancer
por: Miles, Ken
Publicado: (2015)

Assessment of the quality of brain regions and neuroimaging metrics as biomarkers of Alzheimer’s Disease
por: Vaz, Tânia Faria, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mk0oielemheulr5ipp5vbl3eic